|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-6-9
|
|
pubmed:abstractText |
In a previous randomized study, the authors reported that granulocyte colony-stimulating factor (G-CSF) increased the chemotherapy dose-intensity delivered during the consolidation therapy of high-risk childhood acute lymphoblastic leukemia (ALL). The aim of the current study was to perform an economic evaluation in the same cohort.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1077-4114
|
|
pubmed:author |
pubmed-author:AuclercMarie-FrançoiseMF,
pubmed-author:AuvrignonAnne AurtignonAA,
pubmed-author:BadinStéphanieS,
pubmed-author:BaruchelAndréA,
pubmed-author:BauduerFrançoisF,
pubmed-author:BerthouChristianC,
pubmed-author:BordigoniPierreP,
pubmed-author:BraguerDianeD,
pubmed-author:DelormeJeanJ,
pubmed-author:DemeocqFrançoisF,
pubmed-author:GandemerVirginieV,
pubmed-author:LamagnereJean-PierreJP,
pubmed-author:Le CorrollerAnne-Gaelle GAG,
pubmed-author:LeblancThierryT,
pubmed-author:LevergerGuyG,
pubmed-author:MichelGérardG,
pubmed-author:PautardBrigitteB,
pubmed-author:PerelYvesY,
pubmed-author:VannierJean-PierreJP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
441-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12794521-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12794521-Child,
pubmed-meshheading:12794521-Cohort Studies,
pubmed-meshheading:12794521-Cost-Benefit Analysis,
pubmed-meshheading:12794521-Disease-Free Survival,
pubmed-meshheading:12794521-Economics, Pharmaceutical,
pubmed-meshheading:12794521-Female,
pubmed-meshheading:12794521-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:12794521-Humans,
pubmed-meshheading:12794521-Infant,
pubmed-meshheading:12794521-Infant, Newborn,
pubmed-meshheading:12794521-Male,
pubmed-meshheading:12794521-Neutropenia,
pubmed-meshheading:12794521-Palliative Care,
pubmed-meshheading:12794521-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:12794521-Recombinant Proteins,
pubmed-meshheading:12794521-Risk Factors,
pubmed-meshheading:12794521-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia.
|
|
pubmed:affiliation |
Department of Pharmacy, Research Unit INSERM No. 379, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Evaluation Studies
|
